Publications by authors named "Christopher Saeui"

Claim this Profile
A
Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway.
Christopher T Saeui, Sagar R Shah, Beatriz I Fernandez-Gil, Cissy Zhang, Christian Agatemor

ACS Chem Biol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified -Acetylmannosamine (ManNAc) Analogs.
Jian Du, Christian Agatemor, Christopher T Saeui, Rahul Bhattacharya, Xiaofeng Jia

Cells· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the Pharmacodynamics and In Vivo Activity of ENPP1-Fc Through Protein and Glycosylation Engineering.
Paul R Stabach, Kristin Zimmerman, Aaron Adame, Dillon Kavanagh, Christopher T Saeui

Clin Transl Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer Progression.
Christopher T Saeui, Kyung-Cho Cho, Vrinda Dharmarha, Alison V Nairn, Melina Galizzi

Front Chem· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting metabolic glycoengineering to advance healthcare.
Christian Agatemor, Matthew J Buettner, Ryan Ariss, Keerthana Muthiah, Christopher T Saeui

Nat Rev Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Immunotherapy Through Glycodesign.
Matthew J Buettner, Sagar R Shah, Christopher T Saeui, Ryan Ariss, Kevin J Yarema

Front Immunol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining Butyrated ManNAc with Glycoengineered CHO Cells Improves EPO Glycan Quality and Production.
Qiong Wang, Cheng-Yu Chung, Weiming Yang, Ganglong Yang, Sandra Chough, Christopher T Saeui

Biotechnol J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.
Christopher T Saeui, Alison V Nairn, Melina Galizzi, Christopher Douville, Prateek Gowda

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological, Physiochemical, and Drug-Relevant Biological Properties of Short Chain Fatty Acid Hexosamine Analogues Used in Metabolic Glycoengineering.
Christopher T Saeui, Lingshu Liu, Esteban Urias, Justin Morrissette-McAlmon, Rahul Bhattacharya

Mol Pharm· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of absolute expression profiles using multiplexed miRNA analysis.
Yunke Song, Duncan Kilburn, Jee Hoon Song, Yulan Cheng, Christopher T Saeui

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid.
Mohit P Mathew, Elaine Tan, Jason W Labonte, Shivam Shah, Christopher T Saeui

Chembiochem· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.
Haitham A Badr, Dina M M AlSadek, Motawa E El-Houseini, Christopher T Saeui, Mohit P Mathew

Biomaterials· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells.
Mohit P Mathew, Elaine Tan, Christopher T Saeui, Patawut Bovonratwet, Samuel Sklar

Oncotarget· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.
Christopher T Saeui, Esteban Urias, Lingshu Liu, Mohit P Mathew, Kevin J Yarema

Glycoconj J· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodynamic performance of hyaluronic acid versus synovial fluid of the knee in osteoarthritis.
Michael Corvelli, Bernadette Che, Christopher Saeui, Anirudha Singh, Jennifer Elisseeff

Methods· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Surface and Membrane Engineering: Emerging Technologies and Applications.
Christopher T Saeui, Mohit P Mathew, Lingshui Liu, Esteban Urias, Kevin J Yarema

J Funct Biomater· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells.
Yuan Tian, Ruben T Almaraz, Caitlin H Choi, Qing Kay Li, Christopher Saeui

Clin Proteomics· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib.
Mohit P Mathew, Elaine Tan, Christopher T Saeui, Patawut Bovonratwet, Lingshu Liu

Bioorg Med Chem Lett· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical issues in emergency medicine: diagnostic and therapeutic considerations of selected toxic presentations.
Christopher Saeui, Nathan Charlton, William J Brady

Am J Emerg Med· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel sulfamoyl benzamides as selective CB(2) agonists with improved in vitro metabolic stability.
Ian Sellitto, Bertrand Le Bourdonnec, Karin Worm, Allan Goodman, Markku A Savolainen, Christopher T Saeui

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists.
Guo-Hua Chu, Christopher T Saeui, Karin Worm, Damian G Weaver, Allan J Goodman

Bioorg Med Chem Lett· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists.
Karin Worm, Damian G Weaver, Rosalyn C Green, Christopher T Saeui, Doreen-Marie S Dulay

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands.
Karin Worm, Q Jean Zhou, Christopher T Saeui, Rosalyn C Green, Joel A Cassel

Bioorg Med Chem Lett· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis